Successful treatment with Pola-R-mini-CHP for elderly relapsed and refractory mantle cell lymphoma

被引:0
|
作者
Oka, Satoko [1 ]
Akagi, Yuina [1 ]
Ono, Kazuo [2 ]
机构
[1] Japanese Red Cross Soc Wakayama Med Ctr, Div Hematol, Wakayama, Wakayama, Japan
[2] Japanese Red Cross Soc Wakayama Med Ctr, Div Pathol, Wakayama, Japan
关键词
Mantle cell lymphoma (MCL); Relapse/refractory; Pola-R-mini-CHP;
D O I
10.1007/s00277-024-06024-z
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5981 / 5983
页数:3
相关论文
共 50 条
  • [41] Liso-Cel in Relapsed/Refractory Mantle Cell Lymphoma
    Wang, Michael
    ONCOLOGY-NEW YORK, 2024, 38 (07):
  • [42] Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?
    Kirschey, Sebastian
    Wagner, Susanne
    Hess, Georg
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [43] Real-World Evidence of Brexucabtagene Autoleucel for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Camacho, Lina
    Chiappella, Annalisa
    Guadagnuolo, Serafina
    Lopez Corral, Lucia
    Bastos-Oreiro, Mariana
    Delgado Serrano, Javier
    Schmidt, Christian
    Carpio, Cecilia
    Luis Reguera, Juan
    Kwon, Mi
    Martin Garcia-Sancho, Alejandro
    Luigi Zinzani, Pier
    Corradini, Paolo
    Subklewe, Marion
    Barba, Pere
    BLOOD, 2021, 138
  • [44] ECONOMIC EVALUATION OF IBRUTINIB FOR THE TREATMENT OF PATIENTS WITH RELAPSED OR REFRACTORY MANTLE-CELL LYMPHOMA IN MEXICO
    Carlos, F.
    Herrera, M.
    Salazar, A.
    Aguirre, A.
    Gonzalez-Michaca, L.
    VALUE IN HEALTH, 2016, 19 (03) : A249 - A249
  • [45] Ibrutinib and rituximab association: interest of a chemotherapy free treatment in relapsed or refractory mantle cell lymphoma
    Philippe, Laure
    HEMATOLOGIE, 2016, 22 (01): : 12 - 13
  • [46] Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
    Iacoboni, Gloria
    Rejeski, Kai
    Villacampa, Guillermo
    van Doesum, Jaap A.
    Chiappella, Annalisa
    Bonifazi, Francesca
    Lopez-Corral, Lucia
    van Aalderen, Michiel
    Kwon, Mi
    Martinez-Cibrian, Nuria
    Bramanti, Stefania
    Luis Reguera-Ortega, Juan
    Camacho-Arteaga, Lina
    Schmidt, Christian
    Marin-Niebla, Ana
    Jose Kersten, Marie
    Martin Garcia-Sancho, Alejandro
    Zinzani, Pier Luigi
    Corradini, Paolo
    van Meerten, Tom
    Subklewe, Marion
    Barba, Pere
    BLOOD ADVANCES, 2022, 6 (12) : 3606 - 3610
  • [47] Efficacy of R-BAC in relapsed, refractory mantle cell lymphoma post BTK inhibitor therapy
    McCulloch, Rory
    Visco, Carlo
    Eyre, Toby A.
    Frewin, Rebecca
    Phillips, Neil
    Tucker, David L.
    Quaglia, Francesca M.
    McMillan, Annabel
    Lambert, Jonathan
    Crosbie, Nicola
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (04) : 684 - 688
  • [48] Bendamustine therapy for relapsed or refractory low grade B cell lymphoma and mantle cell lymphoma
    Yamada, Toshiki
    Shibata, Yuhei
    Nakamura, Nobuhiko
    Kitagawa, Jun-ichi
    Kanemura, Nobuhiro
    Kasahara, Senji
    Goto, Hideko
    Fukuno, Kenji
    Sawada, Michio
    Tsurumi, Hisashi
    ANNALS OF ONCOLOGY, 2015, 26 : 109 - 109
  • [49] FDA Approval Summary: Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
    Telaraja, Deepti
    Kasamon, Yvette L.
    Collazo, Justin S.
    Leong, Ruby
    Wang, Kun
    Li, Ping
    Dahmane, Elyes
    Yang, Yuching
    Earp, Justin
    Grimstein, Manuela
    Rodriguez, Lisa R.
    Theoret, Marc R.
    Gormley, Nicole J.
    CLINICAL CANCER RESEARCH, 2024, 30 (01) : 17 - 22
  • [50] Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide (ViPOR) in Relapsed/Refractory (R/R) and Treatment-Naive (TN) Mantle Cell Lymphoma (MCL)
    Lakhotia, Rahul
    Pittaluga, Stefania
    Phelan, James
    Yang, Yandan
    Davies-Hill, Theresa
    Simard, Jillian
    Muppidi, Jagan
    Huang, Da Wei
    Thomas, Craig
    Ceribelli, Michele
    Tosto, Frances
    Pradhan, Amynah
    Juanitez, Anna
    Rimsza, Lisa
    Jacob, Allison
    Simmons, Heidi
    Steinberg, Seth
    Jaffe, Elaine
    Staudt, Louis
    Roschewski, Mark
    Wilson, Wyndham
    Melani, Christopher
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S461 - S461